Writing Compliant Product Claims for Adjustable-Stroke Massage Guns
Percussion massage guns occupy a comparatively comfortable regulatory position. They deliver mechanical vibration rather than energy into tissue, and most markets treat them as consumer fitness products rather than medical devices.
That position is easy to lose. The moment a listing claims to treat an injury, relieve a medical condition or replace physiotherapy, the product can be reclassified, and the evidence needed to support such a claim is far beyond what the hardware was designed to produce.
Supportable wording describes the action and the routine: percussive massage, warm-up and recovery routine support, helps relax muscles after exercise. Each of these is factual about the device and sets a realistic expectation for the user.
Two caution areas appear repeatedly. First, avoid anatomical claims about specific conditions, since naming a condition is usually what triggers reclassification. Second, match the instruction leaflet to the packaging, because a leaflet written for a different market is a contradiction reviewers notice immediately.
Aolemon supplies massage guns with claim wording that stays on the cosmetic fitness side of the line, and reviews the manual and the packaging together so that both documents tell the same story in every destination market.
View this adjustable-stroke massage gun on Aolemon
Frequently asked questions
What are the benefits of red-light therapy (LED) devices?
Red and near-infrared LED light supports collagen production, calmer skin and a brighter complexion. LED panels and masks are popular non-invasive tools for salons and home use.
How do I choose an LED light-therapy panel supplier?
Check wavelength accuracy (630/660/850 nm), irradiance, cooling design and certifications. A reliable supplier shares third-party spectral reports and offers OEM branding.
Do LED beauty devices need FDA or CE clearance for export?
For the EU, CE + RoHS is the baseline; the US generally treats non-medical LED beauty devices as low-risk, but claim wording must stay within FDA limits. We advise checking per market before launch.